Valuation: Sanofi

Market Cap 103B 115B 94.54B 85.81B 163B 10,789B 167B 1,131B 451B 5,776B 432B 423B 18,193B P/E 2026 *
13.5x
P/E 2027 * 11.4x
Enterprise Value 114B 128B 105B 95.53B 181B 12,012B 186B 1,259B 502B 6,431B 481B 471B 20,255B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.15x
Free-Float
88.8%
Yield 2026 *
4.97%
Yield 2027 * 5.24%
1 day+2.41%
1 week+6.36%
Current month+7.55%
1 month+19.91%
3 months+13.88%
6 months+17.32%
Current year+3.68%
1 week 81.05
Extreme 81.05
86.1
1 month 70.1
Extreme 70.1
86.1
Current year 69.75
Extreme 69.75
86.1
1 year 69.75
Extreme 69.75
90.79
3 years 69.75
Extreme 69.75
110.88
5 years 69.75
Extreme 69.75
110.88
10 years 62.88
Extreme 62.88
110.88
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer - 2026-08-31
Director TitleAgeSince
Director/Board Member 61 2019-04-29
Director/Board Member 56 2020-04-27
Director/Board Member 65 2020-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
10/14/26 Sell

Executive/Senior Manager

-647 0.0001%
8/20/26 Buy

Chief Executive Officer

1,506 0.0001%
8/20/26 Buy

Head of Human Resources

54 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%+6.36%+0.37%-0.37% 112B
+4.28%+0.07%+52.75%+138.78% 1,206B
+2.13%+4.27%+51.21%+91.36% 665B
+0.68%+1.54%+33.83%+112.47% 515B
+2.77%+0.98%+49.44%+68.46% 381B
+1.38%+0.27%+72.42%+45.30% 362B
+0.29%+1.48%+30.84%+58.32% 307B
+0.98%+1.49%+9.04%+34.78% 289B
+1.04%-0.05%+45.29%+76.18% 249B
+1.46%-0.59%+42.48%+125.82% 207B
Average +1.78%+0.96%+38.77%+75.11% 429B
Weighted average by Cap. +2.30%+0.80%+44.80%+93.53%

Financials

2026 *2027 *
Net sales 48.91B 54.8B 45.01B 40.85B 77.42B 5,136B 79.34B 538B 215B 2,750B 206B 201B 8,661B 51.53B 57.73B 47.42B 43.04B 81.56B 5,411B 83.58B 567B 226B 2,897B 217B 212B 9,125B
Net income 7.68B 8.6B 7.06B 6.41B 12.15B 806B 12.45B 84.5B 33.68B 432B 32.28B 31.59B 1,359B 9.24B 10.35B 8.5B 7.72B 14.62B 970B 14.98B 102B 40.53B 519B 38.85B 38.02B 1,636B
Net Debt 11.64B 13.04B 10.71B 9.72B 18.43B 1,223B 18.89B 128B 51.08B 655B 48.96B 47.91B 2,062B 7.92B 8.87B 7.29B 6.62B 12.54B 832B 12.85B 87.19B 34.75B 445B 33.31B 32.6B 1,403B
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-11-09 €85.76 +2.41% 2,881,635
26-11-06 €83.74 -0.93% 3,228,987
26-11-05 €84.53 +0.51% 3,387,033
26-11-04 €84.10 +3.85% 3,466,706
26-11-03 €80.98 +0.43% 2,794,848
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
85.76EUR
Average target price
95.70EUR
Spread / Average Target
+11.60%